VN9 CLINICAL SERVICES LTD

Company Registration Number:
11406130 (England and Wales)

Unaudited micro entity accounts for the year ended 30 June 2024

Period of accounts

Start date: 01 July 2023

End date: 30 June 2024

VN9 CLINICAL SERVICES LTD

Contents of the Financial Statements

for the Period Ended 30 June 2024

Company Information - 3
Balance sheet - 4
Footnotes to the Balance Sheet - 6

VN9 CLINICAL SERVICES LTD

Company Information

for the Period Ended 30 June 2024




Director: Dr Veena V Nanjangud
Registered office: 98
Hawthorn Chase
Lincoln
England
LN2 4RG
Company Registration Number: 11406130 (England and Wales)

VN9 CLINICAL SERVICES LTD

Balance sheet

As at 30 June 2024


2024
£

2023
£
Current assets: 730 870
Creditors: amounts falling due within one year: ( 96 ) ( 95 )
Net current assets (liabilities): 634 775
Total assets less current liabilities: 634 775
Total net assets (liabilities): 634 775
Capital and reserves: 634 775

VN9 CLINICAL SERVICES LTD

Balance sheet continued

For the year ending 30 June 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 7 October 2024
And Signed On Behalf Of The Board By:

Name: Dr Veena V Nanjangud
Status: Director

The notes form part of these financial statements

VN9 CLINICAL SERVICES LTD

Footnotes to the Financial Statements

for the Period Ended 30 June 2024

  • 1. Employee Information

    Average number of employees: 1

VN9 CLINICAL SERVICES LTD

Footnotes to the Financial Statements

for the Period Ended 30 June 2024

  • 2. Off balance sheet disclosure

    No